Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashish Saxena

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|November 24, 2025
Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancerBobak Parang, Liron Yoffe, Rabia Khan, et al.
Scientific Reports|March 19, 2026
Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cellsBobak Parang, Liron Yoffe, Rabia Khan, et al.
Cancer Letters|July 26, 2020
Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexesLinnea Hases, Rajitha Indukuri, Madeleine Birgersson, et al.
Oncotarget|June 2, 2016
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma modelsSrikanth R Ambati, Jae-Hung Shieh, Benet Pera, et al.
The Journal of Molecular Diagnostics : JMD|March 23, 2025
Comparison of Targeted RNA-Sequencing Platforms for Oncogenic Fusion Detection in Non-Small-Cell Lung CancerAlicia Dillard, Kemin Xu, Yichao Sun, et al.
Chemico-Biological Interactions|March 1, 2011
Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disordersSatish K Srivastava, Umesh C S Yadav, Aramati B M Reddy, et al.
Cancer Medicine|August 8, 2023
Giving information strategically and transparently: A pilot trial of the Oncolo-GIST intervention to promote patients' prognostic understandingHolly G Prigerson, David Russell, Sophia E Kakarala, et al.
The Journal of the Association of Physicians of India|May 8, 2024
Prevalence of Hyperuricemia in Indian Population with HypertensionBijay Patni, Akashkumar Navinprakash Singh, Nagendra Kumar Singh, et al.
Global Heart|December 15, 2021
Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States-India Hypertension Control InitiativeAbhishek Kunwar, Kiran Durgad, Prabhdeep Kaur, et al.
Chemico-Biological Interactions|June 1, 2016
Corrigendum to "Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders" [Chem. Biol. Interact. (2011) 330-338]Satish K Srivastava, Umesh C S Yadav, Aramati B M Reddy, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|November 24, 2025
Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancerBobak Parang, Liron Yoffe, Rabia Khan, et al.
Scientific Reports|March 19, 2026
Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cellsBobak Parang, Liron Yoffe, Rabia Khan, et al.
Cancer Letters|July 26, 2020
Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexesLinnea Hases, Rajitha Indukuri, Madeleine Birgersson, et al.
Oncotarget|June 2, 2016
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma modelsSrikanth R Ambati, Jae-Hung Shieh, Benet Pera, et al.
The Journal of Molecular Diagnostics : JMD|March 23, 2025
Comparison of Targeted RNA-Sequencing Platforms for Oncogenic Fusion Detection in Non-Small-Cell Lung CancerAlicia Dillard, Kemin Xu, Yichao Sun, et al.
Chemico-Biological Interactions|March 1, 2011
Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disordersSatish K Srivastava, Umesh C S Yadav, Aramati B M Reddy, et al.
Cancer Medicine|August 8, 2023
Giving information strategically and transparently: A pilot trial of the Oncolo-GIST intervention to promote patients' prognostic understandingHolly G Prigerson, David Russell, Sophia E Kakarala, et al.
The Journal of the Association of Physicians of India|May 8, 2024
Prevalence of Hyperuricemia in Indian Population with HypertensionBijay Patni, Akashkumar Navinprakash Singh, Nagendra Kumar Singh, et al.
Global Heart|December 15, 2021
Interventions to Ensure the Continuum of Care for Hypertension During the COVID-19 Pandemic in Five Indian States-India Hypertension Control InitiativeAbhishek Kunwar, Kiran Durgad, Prabhdeep Kaur, et al.
Chemico-Biological Interactions|June 1, 2016
Corrigendum to "Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders" [Chem. Biol. Interact. (2011) 330-338]Satish K Srivastava, Umesh C S Yadav, Aramati B M Reddy, et al.
Pageof 12